Keyphrases
Health Economics
100%
Time Use
100%
Narrative Review
100%
Automated Insulin Delivery
100%
Time in Range
100%
Diabetes Modeling
100%
Glucose Control
50%
Hemoglobin A1c (HbA1c)
25%
Economic Evaluation
25%
Type 1 Diabetes Mellitus (T1DM)
25%
Quality-adjusted Life Years
25%
Type I Diabetes
25%
Decision Maker
12%
Economic Model
12%
Treatment Effect
12%
Living with
12%
System Development
12%
Treatment Choice
12%
Type 2 Diabetes Mellitus (T2DM)
12%
Intensive Care Medicine
12%
Glycemic Control
12%
Clinical Endpoints
12%
Blood Glucose
12%
Publicly Available
12%
Economic Value
12%
Quality of Life Assessment
12%
Severe Hypoglycemia
12%
Insulin Pump
12%
Quality Control
12%
Healthcare Interventions
12%
Sensor-based
12%
Holistic Representation
12%
Glycated Hemoglobin A1c
12%
Range Data
12%
Exogenous Insulin
12%
Insulin Therapy
12%
Glucose Sensor
12%
Glucose Monitoring
12%
Health Economic Evaluation
12%
Continuous Glucose Monitoring
12%
Conventional Economics
12%
Appropriate Methodology
12%
Alternative Endpoints
12%
Measure of Treatment Effect
12%
Range Metrics
12%
Nursing and Health Professions
Hemoglobin A1c
100%
Economic Evaluation
100%
Health Economics
100%
Quality Adjusted Life Year
66%
Insulin Dependent Diabetes Mellitus
66%
Glycosylated Hemoglobin
33%
Health Service
33%
Intensive Care
33%
Hypoglycemia
33%
Glucose Blood Level
33%
Non Insulin Dependent Diabetes Mellitus
33%
Insulin Treatment
33%
Quality of Life Measure
33%
Insulin Pump
33%
Continuous Glucose Monitoring
33%
Glucose Sensor
33%
Pharmacology, Toxicology and Pharmaceutical Science
Hemoglobin A1c
100%
Insulin Dependent Diabetes Mellitus
66%
Glycosylated Hemoglobin
33%
Non Insulin Dependent Diabetes Mellitus
33%
Hypoglycemia
33%
Agricultural and Biological Sciences
Endpoints
100%
Quality of Life
25%
Health Service
25%
Blood Glucose
25%
Glycemic Control
25%
Immunology and Microbiology
Quality Adjusted Life Year
100%
Glucose Blood Level
50%
Glycemic Control
50%